查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球血栓管理设备市场——行业规模、份额、趋势、机会、预测、按产品类型、按最终用户、按地区、竞争分析 (2018-2028)
市场调查报告书
商品编码
1244126

全球血栓管理设备市场——行业规模、份额、趋势、机会、预测、按产品类型、按最终用户、按地区、竞争分析 (2018-2028)

Clot Management Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Product Type, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 113 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

在 2024-2028 年的预测期内，全球血栓管理设备市场预计将实现稳定的复合年增长率。

这可能是由于随着世界人口老龄化，心血管疾病增加。 此外，血栓管理设备的技术进步改善了中风等问题的诊断和治疗，患者和医疗保健人员对微创手术的偏好增加，将在预测期内推动对血栓管理设备市场的需求增加。 久坐不动的生活方式、不健康的饮食以及髋、膝和脊柱损伤发生率的增加是预测期内推动全球血栓管理设备市场的一些关键因素。 在过去几年中，与血栓管理设备相关的研究和临床试验显着增加。

对支架回收器的需求不断增长

支架取栓器是用于治疗血栓性疾病的第二代机械取栓设备。 由于饮酒、吸烟、压力、不健康食品和世界各地人口老龄化的增加，心血管疾病的患病率上升正在推动预测期内血栓管理设备市场的增长。 推动市场增长的关键因素之一是越来越多的血栓切除术报销可用性，增加了对产品开发和商业化的公共和私人投资，以及患者对微创手术的关注度正在增加。 通过建立製造设施、研发设施和分销网络，主要参与者继续进行药物开发，市场参与者在新兴国家扩大业务，这将是预测期内血栓管理设备市场增长的重要因素。

增加医疗保险报销的可用性

随着微创手术领域的技术不断突破，医院和外科中心现在正在使用取栓设备结合诊断技术来执行图像引导的取栓术。. 由于在治疗急性缺血性中风中支架和血栓切除装置的使用增加以及慢性血管疾病发病率上升，医院和外科中心进行血栓切除术的频率正在增加。 除此之外，主要的市场参与者正专注于他们的研发部门，以生产用于血栓切除术设备的先进技术。 主要参与者正在与学术研究机构合作以获得对正在进行的临床项目的支持，并且有公共和私人资金支持血栓切除术领域的研究项目以开发新的血栓切除术技术。正在增加，这有望推动整体的增长预测期内的血栓管理设备市场。

市场细分

参与企业

Medtronic Plc.、Concentric Medical, Inc.、Boston Scientific Corporation、Edward Lifesciences Corporation、AngioDynamics, Inc.、LeMaitre Vascular, Inc.、Teleflex Incorporated、Johnson & Johnson、Strub Medical GmbH & Co.KG、Cook Group Incorporated等，是在全球血栓管理设备市场上运营的主要参与者之一。

范围

本报告将全球血栓管理器械市场分为以下几类，行业趋势详述如下：

血栓管理设备市场，按产品类型：

  • 神经血管栓塞装置
  • 取栓球囊导管
  • 经皮取栓装置
  • 导管定向溶栓装置
  • 其他

最终用户的血栓管理设备市场：

  • 用于医院和诊所
  • 门诊中心
  • 其他

按地区划分的血栓管理设备市场：

  • 北美
    • 美国
    • 墨西哥
    • 加拿大
  • 欧洲
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥伦比亚
  • 中东和非洲
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • 埃及
    • 土耳其人

竞争格局

公司概况：对全球血栓管理设备市场主要参与者的深入分析。

可自定义：

根据市场数据，TechSci Research 根据公司的具体需求提供定制服务。 该报告可以定制为：

公司信息

  • 对其他市场参与者（最多 5 家公司）进行深入分析和概况分析。

内容

第 1 章概述

  • 市场定义
  • 市场范围
    • 目标市场
    • 研究目标年份
    • 主要市场细分

第二章研究方法论

  • 调查目的
  • 基线调查方法
  • 主要行业合作伙伴
  • 主要协会和次要信息
  • 调查方法
  • 数据三角测量和验证
  • 假设和限制

第 3 章执行摘要

  • 市场概览
  • 主要市场细分概述
  • 主要市场参与者概览
  • 主要地区/国家概览
  • 市场驱动因素、挑战和趋势概述

第 4 章 VOC（客户之声）

第 5 章血栓管理设备的全球市场前景

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按产品类型（神经血管栓塞装置、栓塞球囊导管、经皮取栓装置、导管直接溶栓装置等）
    • 按最终用户（医院/诊所、门诊诊所、其他）
    • 按公司分类（2022 年）
    • 按地区
  • 市场地图
    • 按产品类型
    • 最终用户
    • 按地区

第6章北美血栓管理器械市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按产品类型
    • 最终用户
    • 按国家
  • 北美：国家/地区分析
    • 美国
    • 墨西哥
    • 加拿大

第 7 章：欧洲血栓管理设备的市场前景

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按产品类型
    • 最终用户
    • 按国家
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第 8 章亚太地区血栓形成和止血设备市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按产品类型
    • 最终用户
    • 按国家
  • 亚太地区：国家/地区分析
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚

第 9 章：南美血栓管理设备的市场前景

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按产品类型
    • 最终用户
    • 按国家
  • 南美洲：：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章中东和非洲血栓和止血设备市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按产品类型
    • 最终用户
    • 按国家
  • MEA：国家分析
    • 南非血栓形成装置
    • 沙特阿拉伯血栓止血装置
    • 阿联酋血栓形成装置
    • 埃及血栓止血器
    • 土耳其血栓治疗仪

第 11 章市场动态

  • 司机
  • 任务

第12章市场趋势与发展

  • 近期趋势
  • 併购
  • 产品发布

第13章竞争格局

  • 业务概览
  • 企业概况
  • 产品服务
  • 财务信息（公开数据）
  • 最新趋势
  • SWOT 分析
    • Medtronic Plc.
    • Concentric Medical, Inc.
    • Boston Scientific Corporation
    • Edward LifeSciences Corporation
    • AngioDynamics, Inc.
    • LeMaitre Vascular, Inc.
    • Teleflex Incorporated
    • Johnson & Johnson
    • Strub Medical GmbH & Co. KG
    • Cook Group Incorporated

第14章 战略建议

简介目录
Product Code: 14585

Global clot management devices market is expected to register a steady CAGR during the forecast period, 2024-2028. This can be ascribed to the increasing number of cardiovascular diseases along with the rising aging population across the world. Additionally, the advancement of technologies in clot management devices to improve the diagnosis and treatment of problems like stroke and the growing preference for minimally invasive procedures by both patients and healthcare increased the demand for the clot management device market for the forecast period. Sedentary lifestyles and unhealthy dietary habits and increasing instances of hip, knee, and spinal injuries across the globe, are some of the major factors driving the global clot management device market during the forecast period. The research and clinical trial related to clot management devices has significantly increased over the years.

Rising Demand for Stent Retrievers

Stent retrievers are second-generation mechanical thrombectomy products utilized for the treatment of thrombotic disorders. The increasing prevalence of cardiovascular disease because of the increase in alcohol consumption, smoking, stress, and unhealthy foods and the growing aging population across the world, are propelling the clot management device market growth during the forecast period. One of the important factors that drive the market growth is the increasing availability of reimbursement of thrombectomy procedures, rising public and private investments for product development and commercialization, and increasing patient emphasis on minimally invasive procedures. Ongoing drug developments by leading companies and expansion of the presence in emerging countries by the market players through the establishment of manufacturing facilities, research and development facilities, and distribution networks are the important factors that significantly contribute to the growth of the clot management devices market during the forecast period.

Increasing Availability of Medical Reimbursements

With continued technical breakthroughs in the field of minimally invasive operations, thrombectomy systems are currently being used in hospitals and surgical centers in collaboration with diagnostic technologies for image-guided thrombectomy procedures. The frequency of thrombectomy procedures performed in hospitals and surgical centers is rising due to the increased use of stent and clot retrievers in treating acute ischemic stroke and the rising incidence of chronic vascular illnesses. Apart from this, the main market players are focusing on the research and development sector to create advanced technology in thrombectomy devices. Major players are collaborating with academic and research institutes to get support on their ongoing clinical projects and rising public-private funding to support research projects in the field of thrombectomy to develop novel thrombectomy technology, which is expected to drive the overall clot management device market growth during the forecast period.

Market Segmentation

Global Clot Management Devices market is segmented based on product type, end-user, and region. Based on product type, the market can be segmented into neurovascular embolectomy devices, embolectomy balloon catheters, percutaneous thrombectomy devices, catheter-directed thrombolysis devices, and others. Based on end users, the market can be segmented into hospitals & clinics, ambulatory care centers, and others. Regionally, Europe dominated the market among Asia Pacific, North America, Middle East & Africa, and South America. In terms of country, the United States is dominating the global clot management devices market. This can be ascribed to the increasing number of cost-effective devices in the healthcare sector. According to the World Health Organization (WHO), the number of people suffering from deep vein thrombosis (DVT) and pulmonary embolism (PE) is much larger than people suffering from AIDS and cancer. During the year 2015, around 9,00,000 people were diagnosed with DVT & PE in the United States.

Market Players

Medtronic Plc., Concentric Medical, Inc., Boston Scientific Corporation, Edward Lifesciences Corporation, AngioDynamics, Inc., LeMaitre Vascular, Inc., Teleflex Incorporated, Johnson & Johnson, Strub Medical GmbH & Co. KG, Cook Group Incorporated are some of the leading players operating in the Global Clot Management Devices Market.

Report Scope:

In this report, Global Clot Management Devices market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Clot Management Devices Market, By Product Type:

  • Neurovascular Embolectomy Devices
  • Embolectomy Balloon Catheters
  • Percutaneous Thrombectomy Devices
  • Catheter-Directed Thrombolysis Devices
  • Others

Clot Management Devices Market, By End User:

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Clot Management Devices Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Clot Management Devices Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Clot Management Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices, Catheter Directed Thrombolysis Devices, Others)
    • 5.2.2. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 5.2.3. By Company (2022)
    • 5.2.4. By Region
  • 5.3. Market Map
    • 5.3.1. By Product Type
    • 5.3.2. By End User
    • 5.3.3. By Region

6. North America Clot Management Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Clot Management Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By End User
    • 6.3.2. Mexico Clot Management Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By End User
    • 6.3.3. Canada Clot Management Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By End User

7. Europe Clot Management Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Clot Management Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By End User
    • 7.3.2. Germany Clot Management Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Clot Management Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Clot Management Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Clot Management Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By End User

8. Asia-Pacific Clot Management Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Clot Management Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By End User
    • 8.3.2. India Clot Management Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By End User
    • 8.3.3. South Korea Clot Management Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By End User
    • 8.3.4. Japan Clot Management Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Clot Management Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By End User

9. South America Clot Management Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Clot Management Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By End User
    • 9.3.2. Argentina Clot Management Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By End User
    • 9.3.3. Colombia Clot Management Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By End User

10. Middle East and Africa Clot Management Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Clot Management Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By End User
    • 10.3.2. Saudi Arabia Clot Management Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By End User
    • 10.3.3. UAE Clot Management Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By End User
    • 10.3.4. Egypt Clot Management Devices Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Product Type
        • 10.3.4.2.2. By End User
    • 10.3.5. Turkey Clot Management Devices Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Product Type
        • 10.3.5.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Competitive Landscape

  • 13.1. Business Overview
  • 13.2. Company Snapshot
  • 13.3. Products & Services
  • 13.4. Financials (As reported)
  • 13.5. Recent Developments
  • 13.6. SWOT Analysis
    • 13.6.1. Medtronic Plc.
    • 13.6.2. Concentric Medical, Inc.
    • 13.6.3. Boston Scientific Corporation
    • 13.6.4. Edward LifeSciences Corporation
    • 13.6.5. AngioDynamics, Inc.
    • 13.6.6. LeMaitre Vascular, Inc.
    • 13.6.7. Teleflex Incorporated
    • 13.6.8. Johnson & Johnson
    • 13.6.9. Strub Medical GmbH & Co. KG
    • 13.6.10. Cook Group Incorporated

14. Strategic Recommendations